$PCSA
Processa Pharmaceuticals, Inc. Common
XNAS
Why is PCSA down today? It is at $2.22 (-27.21%), and our scanner flagged it 8 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PCSA spikes, and full due diligence on PCSA — key stats, earnings, dilution and insider activity. Free.
Get free $PCSA alerts the moment volume spikes
Our scanner flagged $PCSA 8 times in the last 30 days. Create a free account to track $PCSA, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $2.22
- Change today
- -27.21%
- Previous close
- $3.05
- 52-week range
- $1.67 – $14.24
- Market cap
- $8M
- Institutional own.
- 7.27%
- Total held
- 7.3%
- Tradeable float
- 2.6M 93% of shares · after 7% institutions
- Short interest
- 104K ▲ +20% vs prior · as of 2026-07-15
- Short % of float
- 4.1%
- Days to cover
- 1.4d
- Avg daily volume
- 339K
- Next earnings
- Aug 6 · in 8d
- Exchange
- XNAS
- 5mthin
- 3.6x
- 15mthin
- 3.4x
- 1hthin
- 4.1x
- 1D
- 147x
Get free PCSA + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $PCSA down today?
PCSA is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 7 unusual-volume and momentum alerts on PCSA today, peaking at 43.1x its normal volume. Fresh from the SEC: Processa Pharmaceuticals, Inc.: brings into Processa's pipeline Vidya's lead asset, VT-7208, a next-generation,. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystMerger / acquisition agreementPrice $0.0001/shareReverse split plannedStatus pending stockholder approval, from the latest SEC filing. Read it →Insiders
Insiders buying8 open-market buys26 buys, 0 sells last 3 months (41/0 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ng George K Officer | Bought (open market) | +3K 0.1% of company | added 25% | 15K | $6K at $1.93 | Jul 1, 26 |
Young David Officer | Bought (open market) | +3K 0.09% of company | added 13% | 22K | $5K at $1.93 | Jun 30, 26 |
Skibsted Russell Officer | Bought (open market) | +3K 0.1% of company | added 24% | 17K | $6K at $1.93 | Jun 30, 26 |
Lin Patrick Officer | Bought (open market) | +2K 0.08% of company | added 19% | 13K | $4K at $1.93 | Jun 30, 26 |
Guy Wendy Officer | Bought (open market) | +2K 0.09% of company | added 20% | 14K | $5K at $1.93 | Jun 30, 26 |
Baluch Khoso Director | Other | 203 | added 8.7% | 3K | n/a | Jun 26, 26 |
Neal James R Director | Other | 203 | added 25% | 1K | n/a | Jun 26, 26 |
Pannu Geraldine Director | Other | 203 | added 9.3% | 2K | n/a | Jun 26, 26 |
Yorke Justin W Director | Other | 203 | added 100% | 353 | n/a | Jun 26, 26 |
Guy Wendy Officer | Bought (open market) | +2K 0.08% of company | added 22% | 12K | $5K at $2.22 | Jun 15, 26 |
Lin Patrick Officer | Bought (open market) | +2K 0.07% of company | added 20% | 11K | $4K at $2.22 | Jun 15, 26 |
Ng George K Officer | Bought (open market) | +2K 0.09% of company | added 25% | 12K | $5K at $2.22 | Jun 15, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
$PCSA Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$PCSA Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
PCSA stock FAQ
Why is $PCSA down today?
PCSA is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 7 unusual-volume and momentum alerts on PCSA today, peaking at 43.1x its normal volume. Fresh from the SEC: Processa Pharmaceuticals, Inc.: brings into Processa's pipeline Vidya's lead asset, VT-7208, a next-generation,. A material company disclosure like this is often the real catalyst behind a move of this size.
What is the PCSA stock price today?
PCSA last traded at $2.22, down 27.21% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does PCSA report earnings?
Processa Pharmaceuticals, Inc. Common (PCSA) is next expected to report earnings on Thursday, August 6, 2026, about 8 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live PCSA alerts?
The PCSA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PCSA 8 times in the last 30 days.
What exchange is PCSA on?
PCSA (Processa Pharmaceuticals, Inc. Common) trades on XNAS, with a market cap of about $8M.
Is PCSA good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PCSA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.